Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer
Phase 1
Terminated
- Conditions
- Unresectable Metastatic Colo-rectal Cancer
- Interventions
- Procedure: Chemoembolization with irinotecan Bead
- First Posted Date
- 2009-01-05
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- Generic Devices Consulting, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT00816777
- Locations
- 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸Lahey Clinic, Burlington, Massachusetts, United States
News
No news found